{"id":"W2553056958","doi":"10.1097/fjc.0000000000000445","title":"Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region: A Phase 3 Randomized Controlled Trial","year":2016,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cardiome (Canada)","funders":"Cardiome Pharma Corp.","keywords":"Medicine; Cardioversion; Placebo; Atrial fibrillation; Sinus rhythm; Internal medicine; Cardiology; Anesthesia; Clinical endpoint; Randomized controlled trial; Adverse effect","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001927716,0.001136325,0.002588702,0.0002593169,0.0004259023,0.001004668,0.0007648945,0.001808758,0.003933854],"category_scores_gemma":[0.001867494,0.0004817317,0.002034417,0.00033996,0.0008787455,0.0007653025,0.0002581651,0.002325657,0.0005822645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003596679,"about_ca_system_score_gemma":0.000890407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005162871,"about_ca_topic_score_gemma":0.001066605,"domain_scores_codex":[0.9992974,0.0003974126,0.00006445539,0.00009973435,0.00006097337,0.00008002279],"domain_scores_gemma":[0.9989486,0.000341929,0.0002859955,0.00007985096,0.00007321976,0.0002703916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9696335,0.005421791,0.0008798626,0.0009740018,0.00121877,0.00007438571,0.0000660128,0.0002389005,0.004544064,0.00009509533,0.0006378741,0.01621572],"study_design_scores_gemma":[0.9641466,0.03263988,0.00187552,0.00003634473,0.0003832708,0.00003840819,0.0000127226,0.0002657751,0.0002843275,0.00005645741,0.0002507248,0.000009846633],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834351,0.00824138,0.0009360785,0.0006870836,0.0005125028,0.00380889,0.0006521626,0.0001549477,0.001571795],"genre_scores_gemma":[0.9874552,0.003910151,0.001552561,0.001138873,0.0004126696,0.003843092,0.0006354277,0.00002553404,0.001026425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003933854,"threshold_uncertainty_score":0.01316005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04227251242056037,"score_gpt":0.3486379242290639,"score_spread":0.3063654118085035,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}